Clinical Trial Results:
Estudio de Fase Ib, multicéntrico, de determinación de dosis, con un fase II doble ciego, controlado con placebo, aleatorizado, adaptativo, que utiliza varias dosis IV repetidas de BHQ880 en combinación con ácido zoledrónico, en pacientes con mieloma refractario o en recaída y con complicaciones esqueléticas previas.
Summary
|
|
EudraCT number |
2008-000411-15 |
Trial protocol |
ES IT GB DE GR |
Global completion date |
09 Dec 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Dec 2016
|
First version publication date |
15 Dec 2016
|
Other versions |
|
Summary report(s) |
CBHQ880A2102.CTR.02Nov2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.